XML 30 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Statements of Cash Flows (Unaudited) (USD $)
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Operating activities:    
Net loss $ (3,224,486) $ (2,091,887)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 2,163,530 2,603,931
Provision for doubtful accounts 25,520 298,000
Loss on write-off of note receivable 100,745 0
Deferred compensation 318,975 0
Stock based compensation 726,711 333,357
Change in operating assets and liabilities:    
Restricted cash 137,119 61,402
Accounts receivable 1,227,703 (1,006,636)
Prepaid expenses and other assets 90,657 (89,230)
Accounts payable (996,225) 1,188,406
Deferred revenue (1,838) (54,305)
Other accrued expenses and current liabilities (194,077) (498,577)
Net cash provided by operating activities from continuing operations 374,334 744,461
Net cash (used in) provided by operating activities from discontinued operations (296,424) (780,459)
Net cash provided by operating activities 77,910 (35,998)
Investing activities:    
Purchasing of equipment and software (245,382) (482,506)
Purchase of names database and exclusivity rights (1,543,247) (1,034,917)
Net cash used in investing activities (1,788,629) (1,517,423)
Financing activities:    
Proceeds from sale of common stock, net 2,680,036 0
Prinicipal payments made on term note payable 0 (1,412,000)
Advances from credit note 4,396,744 14,408,000
Payments on credit note (3,569,625) (14,959,000)
Net cash (used in) provided by financing activities 3,507,155 (1,963,000)
Net (decrease) increase in cash 1,796,436 (3,516,421)
Cash, beginning of year 118,561 4,843,128
Cash, end of year 1,914,997 1,326,707
Supplemental information:    
Interest paid 271,506 291,636
Equipment under capital leases 0 19,236
Restricted Advances on term note payable 475,000 0
Payment of litigation settlements with common stock $ 365,400 $ 0